Pharmaceuticals
As you can see from the following link (https://www.washingtontimes.com/news/2018/dec/18/elizabeth-warren-us-govt-ought-make-generic-drugs/), Elizabeth Warren is proposing that the government now go into the manufacture of pharmaceuticals. I have proposed in two prior blogs (http://njhealthcareblog.com/2018/05/17/pharmaceutical-pricing/; and http://njhealthcareblog.com/2018/11/08/pharmaceutical-pricing-update-to-may-17-2018-blog/) that we take a much more direct and simpler approach…that is that we legislatively impose the Most Favored Nation’s treatment on the […]
December 2018 Regulatory Developments
Here are the most recent health care related regulatory developments as published in the New Jersey Register in December 2018: On December 3, 2018, at 50 N.J.R. 2434(a), the Department of Health published a notice acknowledging the receipt of the petition for rulemaking submitted by Laura I. Thevenot, Chief Executive Officer, American Society for Radiation […]
NJ DOBI Issues Out of Network Guidance
On Tuesday November 20, 2018, the Department of Banking and Insurance (“DOBI”) published Bulletin 18-14 (“Bulletin”) to help carriers, health care providers and other interested parties meet their obligations under the Out of Network Consumer Protection, Transparency, Cost Containment and Accountability Act (the “Act”), which was enacted on June 1, 2018 and became effective on […]